(RTTNews) - Pasithea Therapeutics Corporation (KTTA) said on Monday that it has appointed Kartik Krishnan as chief medical officer with effect from May 1.
(RTTNews) - Pasithea Therapeutics Corporation (KTTA) said on Monday that it has appointed Kartik Krishnan as chief medical officer with effect from May 1.
RLJ Lodging Trust press release ( RLJ ): Q1 FFO of $0.33 beats by $0.06 . Revenue of $339.97M (+3.6% Y/Y) beats by $15.73M . Comparable RevPAR of $148.55, an increase of 4.8% over the prior year Comparable Hotel Revenue of $340.0 million, an increase of 5.4% over the prior year FY26 FFO consensus of $1.33 Click to enlarge FY 2026 Comparable RevPAR Growth +1.5% to +3.5% Comparable Hotel EBITDA $356...
RLJ Lodging Trust press release ( RLJ ): Q1 FFO of $0.33 beats by $0.06 . Revenue of $339.97M (+3.6% Y/Y) beats by $15.73M . Comparable RevPAR of $148.55, an increase of 4.8% over the prior year Comparable Hotel Revenue of $340.0 million, an increase of 5.4% over the prior year FY26 FFO consensus of $1.33 Click to enlarge FY 2026 Comparable RevPAR Growth +1.5% to +3.5% Comparable Hotel EBITDA $356M to $380M Adjusted EBITDA $324M to $348M Adjusted FFO per diluted share $1.29 to $1.45 Click to enlarge More on RLJ Lodging Trust RLJ Lodging Trust 2025 Q4 - Results - Earnings Call Presentation RLJ Lodging Trust: One Of The Best High-Yield Opportunities In Today's Market RLJ Lodging Remains A High-Yield REIT That Is Betting On Hotel Upgrades RLJ Lodging Trust Q1 2026 Earnings Preview RLJ Lodging Trust declares $0.15 dividend
MattGush/iStock via Getty Images Rating: Buy (aggressive growth investors) / Hold (everyone else) Current Price: ~$145 12-Month Price Target: $266 (base case) | Bull: $386 | Bear: $125 The Thesis I rate Nebius Group ( NASDAQ: NBIS ) a Buy for aggressive growth investors and a Hold for most others. I had first stumbled across Nebius as I was researching for "AI bottlenecks" back in Jan 2026 where i...
MattGush/iStock via Getty Images Rating: Buy (aggressive growth investors) / Hold (everyone else) Current Price: ~$145 12-Month Price Target: $266 (base case) | Bull: $386 | Bear: $125 The Thesis I rate Nebius Group ( NASDAQ: NBIS ) a Buy for aggressive growth investors and a Hold for most others. I had first stumbled across Nebius as I was researching for "AI bottlenecks" back in Jan 2026 where it was sitting around $60-70 a share. Nebius fits the criteria because it is essentially the AI landlord renting out critical resources such as power, chips and space to major AI consumers/investors such as the Mag7 ( which Nebius has already received investments from! ). There is a years-long queue for companies to connect to the electricity grid. Nebius is skipping the line by building its own data centres at a rapid pace, and still can't keep up with demand. Nebius owns the "bottleneck," giving them massive pricing power over giants like Meta and Microsoft who simply can't find this capacity anywhere else. The disconnect here is straightforward. The market is still partially pricing NBIS like an unproven cloud startup, underestimating the physical moats it is building. In Q4 2025 , Nebius reported $227.7 million (M) in total revenue, up 547% year-over-year. Its core AI-cloud segment grew by 802%, exiting the year with an Annual Recurring Revenue of $1.25 billion (B)— beating management's own guidance range of $900 million to $1.1 billion by 14% at the high end. The company is sold out of capacity. With approximately $46 billion in contracted backlog from Meta Platforms (NASDAQ: META) and Microsoft (NASDAQ: MSFT), the demand is now massively built in. The question that remains is if management can build the data centers fast enough to collect it. What Nebius Actually Is Nebius Group was formed in Europe following the divestment of Yandex's international assets. Arkady Volozh (CEO) had previously built Yandex into a $30 billion tech company and initiated a clean separation ...
In the last week, the United States market has stayed flat, but it is up 28% over the past year with earnings forecasted to grow by 16% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often demonstrate strong alignment between management and shareholder interests.
In the last week, the United States market has stayed flat, but it is up 28% over the past year with earnings forecasted to grow by 16% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often demonstrate strong alignment between management and shareholder interests.
Many older Americans look at Medicare as a safety net, like Social Security. But while both programs can change from year to year, Social Security benefits usually change for the better. With Social Security, your monthly checks are eligible for an annual cost-of-living adjustment . There are actually provisions to prevent those benefits from decreasing from one year to the next. Image source: Get...
Many older Americans look at Medicare as a safety net, like Social Security. But while both programs can change from year to year, Social Security benefits usually change for the better. With Social Security, your monthly checks are eligible for an annual cost-of-living adjustment . There are actually provisions to prevent those benefits from decreasing from one year to the next. Image source: Getty Images. Continue reading
(RTTNews) - Asian equity markets rallied on Monday tracking Wall Street's strong performance on Friday attributed mainly to strong corporate earnings. The geopolitical stress from the Middle East conflict however capped gains. Markets in China and Japan are closed for a holiday.
(RTTNews) - Asian equity markets rallied on Monday tracking Wall Street's strong performance on Friday attributed mainly to strong corporate earnings. The geopolitical stress from the Middle East conflict however capped gains. Markets in China and Japan are closed for a holiday.
Mikhail Konoplev/iStock via Getty Images Co-authored with Beyond Saving Remember "Blue Light Specials?" My mom and grandma loved them, and as a kid, I hated them because it meant sheer boredom as Mom and Grandma would stroll around K-Mart looking at every special. It probably wasn't that long, but it felt like hours of mind-numbing boredom. Going up and down every aisle, Mom and Grandma carried on...
Mikhail Konoplev/iStock via Getty Images Co-authored with Beyond Saving Remember "Blue Light Specials?" My mom and grandma loved them, and as a kid, I hated them because it meant sheer boredom as Mom and Grandma would stroll around K-Mart looking at every special. It probably wasn't that long, but it felt like hours of mind-numbing boredom. Going up and down every aisle, Mom and Grandma carried on, "Oh look at this, isn't this nice? And it's discounted 50%!" Of course, looking for a deal on something that you want to buy anyway is just sound budget management. Now that I'm older, I can appreciate that. I can also appreciate that in the digital age, looking for specials no longer requires walking through a physical store and following the blue lights. My favorite discounts are discounts on dividend stocks. The CEF (closed-end fund) structure allows for funds to trade at a discount to their net asset value, meaning that it is cheaper to buy the fund than it would be to buy all the holdings in the fund. Buying cheaper means higher dividend yields. Let's look at a couple of "bluelight specials" today. Pick #1: BCX – Yield 6.8% BlackRock Resources & Commodities Strategy Trust ( BCX ) is a CEF that invests in commodities. In our Market Outlooks available to members , we've been discussing the risk of global food shortages as the Strait of Hormuz remains closed. As of the time of this writing, the Strait is still closed, and there is no clear line of sight for if, when, or how that will change. The thing with the world is that it doesn't pause for the convenience of humans. The seasons are changing whether we want them to or not. In the United States, corn farmers have to be fertilizing right now. They can't come back in June when fertilizer is available and start applying the fertilizer they should be applying right now. You follow the planet's schedule, and if you miss it, then your yields are lower. Farmers are making the decision today, based on the current prices of f...
(RTTNews) - Indivior Pharmaceuticals, Inc. (INDV), on Monday, announced that announced a $175 million accelerated share repurchase agreement with Barclays PLC (BARC.L, BCS) under its existing $400 million buyback program.
(RTTNews) - Indivior Pharmaceuticals, Inc. (INDV), on Monday, announced that announced a $175 million accelerated share repurchase agreement with Barclays PLC (BARC.L, BCS) under its existing $400 million buyback program.
Tyson Foods press release ( TSN ): Q2 Non-GAAP EPS of $0.87 beats by $0.09 . Revenue of $13.65B (+4.4% Y/Y) beats by $40M . Total CompanyWe anticipate total company adjusted operating income of $2.2 billion to $2.4 billion for fiscal 2026.RevenueWe expect sales to be up 2% to 4% in fiscal 2026 as compared to fiscal 2025.Capital ExpendituresWe expect capital expenditures of $0.7 billion to $1.0 bil...
Tyson Foods press release ( TSN ): Q2 Non-GAAP EPS of $0.87 beats by $0.09 . Revenue of $13.65B (+4.4% Y/Y) beats by $40M . Total CompanyWe anticipate total company adjusted operating income of $2.2 billion to $2.4 billion for fiscal 2026.RevenueWe expect sales to be up 2% to 4% in fiscal 2026 as compared to fiscal 2025.Capital ExpendituresWe expect capital expenditures of $0.7 billion to $1.0 billion in fiscal 2026. Capital expenditures include investments in profitimprovement projects as well as projects for maintenance and repair. Shares +1.2% PM. More on Tyson Foods Tyson Foods: Pivoting Beyond Cyclicality Into Structural Growth Tyson Foods: Improvements Look Priced In Here, But Rising Protein Demand Could Be A Catalyst Tyson Foods Still Needs To Prove This Time Is Different U.S. struggles to define ‘ultraprocessed foods’ as Kennedy pushes crackdown Tyson Foods Q2 2026 Earnings Preview
frender CoStar Group ( CSGP ) stock rose 2.8% in Monday premarket trading after CEO Andy Florance bought $2.5M of stock i n the open market on Friday, the company disclosed in an SEC filing. He acquired the shares in two transactions. In one, he purchased 68,330 shares at an average price of $35.17 each. In the second, he acquired 3,100 shares at an average price of $35.82 per share. Florance's pu...
frender CoStar Group ( CSGP ) stock rose 2.8% in Monday premarket trading after CEO Andy Florance bought $2.5M of stock i n the open market on Friday, the company disclosed in an SEC filing. He acquired the shares in two transactions. In one, he purchased 68,330 shares at an average price of $35.17 each. In the second, he acquired 3,100 shares at an average price of $35.82 per share. Florance's purchases came after the real estate analytics company's stock had dropped 54% in the past year. In that same period, the S&P 500 rose 29%. The transactions follow a $2.5M purchase he made on March 2, acquiring 55,720 shares at $44.52 each. After his latest purchases, Florance holds 1.72M shares, or about 0.4% of the company's 408.4M shares outstanding at April 27, 2026. More on CoStar Group CoStar Group, Inc. (CSGP) Q1 2026 Earnings Call Transcript CoStar Group, Inc. 2026 Q1 - Results - Earnings Call Presentation CoStar: Even After The Fall, This Stock Remains Vulnerable In The AI Age Costar raises 2026 adjusted EBITDA outlook to $780M-$820M while targeting residential segment profitability in Q2 2026 CoStar Group Non-GAAP EPS of $0.23 beats by $0.05, revenue of $897M in-line
Max Rushden is joined by Barry Glendenning , Jonathan Wilson and Barney Ronay to discuss all the weekend’s Premier League action Rate, review, share on Apple Podcasts and join the conversation on email . On today’s pod: Arsenal deliver what some are calling a “statement victory” with a commanding 3-0 win over Fulham . With Bukayo Saka back and firing and Viktor Gyökeres grabbing two goals, are the...
Max Rushden is joined by Barry Glendenning , Jonathan Wilson and Barney Ronay to discuss all the weekend’s Premier League action Rate, review, share on Apple Podcasts and join the conversation on email . On today’s pod: Arsenal deliver what some are calling a “statement victory” with a commanding 3-0 win over Fulham . With Bukayo Saka back and firing and Viktor Gyökeres grabbing two goals, are they still the team to beat in the title race? Continue reading...
Investing.com -- Alibaba has emerged as the biggest winner in China’s AI race, according to a new survey by Morgan Stanley, as overall IT spending growth falls to a record low amid growing economic pressures.
Investing.com -- Alibaba has emerged as the biggest winner in China’s AI race, according to a new survey by Morgan Stanley, as overall IT spending growth falls to a record low amid growing economic pressures.
Victor Golmer SAP SE ( SAP ) is acquiring Prior Labs, expanding its AI efforts and adding a leading research team to the company. Prior Labs will continue to operate as an independent entity, with SAP committing to invest more than €1 billion over the next four years to scale it into a globally leading frontier AI lab for the structured data that runs the world's businesses. Terms of the deal were...
Victor Golmer SAP SE ( SAP ) is acquiring Prior Labs, expanding its AI efforts and adding a leading research team to the company. Prior Labs will continue to operate as an independent entity, with SAP committing to invest more than €1 billion over the next four years to scale it into a globally leading frontier AI lab for the structured data that runs the world's businesses. Terms of the deal were not disclosed. The transaction is still pending regulatory approval. With over 3 million downloads, Prior Labs' TabPFN is a widely adopted open-source tool for tabular AI, supporting a dynamic developer ecosystem. More on SAP SE SAP: Finally, It's Time To Buy This Entrenched Software Giant (Upgrade) SAP SE (SAP) Q1 2026 Earnings Call Transcript SAP SE 2026 Q1 - Results - Earnings Call Presentation SAP Q1 results demonstrate product momentum as cloud margins improve: analysts Biggest stock movers Friday: MXL, INTC, COUR, CHTR, MXL, and more
Sundry Photography/iStock Editorial via Getty Images Shares of BlackBerry ( BB ) surged about 15% premarket on Monday after a Wall Street Journal report about the company's QNX unit head John Wall discussing the company's technology. Wall discussed how the Canadian company's key product is not hardware but the hidden software QNX, which is in 275M cars on the road today. QNX powers these vehicles ...
Sundry Photography/iStock Editorial via Getty Images Shares of BlackBerry ( BB ) surged about 15% premarket on Monday after a Wall Street Journal report about the company's QNX unit head John Wall discussing the company's technology. Wall discussed how the Canadian company's key product is not hardware but the hidden software QNX, which is in 275M cars on the road today. QNX powers these vehicles for Advanced Driver Assistance Systems, or ADAS, digital cockpits, and infotainment, among other things. The company's shares have soared approximately 43% year-to-date. Last month, BlackBerry reported its fiscal fourth quarter results and first quarter fiscal 2027 outlook, which beat estimates. The company also announced an expanded partnership with Nvidia in April for robotics and edge computing. In April, the stock closed in the red only five days, marking extended rallies in the month. The company is expected to report fiscal first quarter results in June, but the date has not been announced yet. More on BlackBerry BlackBerry: The Turnaround Is Here (Rating Upgrade) BlackBerry: Auto Software Play BlackBerry Is Finally Back (Rating Upgrade) BlackBerry's QNX partners with TKMS to support Canada’s next-gen submarine program Biggest stock movers Thursday: BB, ZS, APLD, and more
Twist Bioscience press release ( TWST ): Q2 GAAP EPS of -$0.71 misses by $0.23 . Revenue of $110.72M (+19.3% Y/Y) beats by $3.06M . DNA Synthesis and Protein Solutions (DSPS) revenue grew 28% to $53.3 million for the second quarter of fiscal 2026 compared to $41.6 million for the same period of fiscal 2025, and grew 4% sequentially, compared to $51.1 million for the first quarter of fiscal 2026. N...
Twist Bioscience press release ( TWST ): Q2 GAAP EPS of -$0.71 misses by $0.23 . Revenue of $110.72M (+19.3% Y/Y) beats by $3.06M . DNA Synthesis and Protein Solutions (DSPS) revenue grew 28% to $53.3 million for the second quarter of fiscal 2026 compared to $41.6 million for the same period of fiscal 2025, and grew 4% sequentially, compared to $51.1 million for the first quarter of fiscal 2026. NGS Applications ( NGS ) revenue grew 12% to $57.4 million for the second quarter of fiscal 2026 compared to $51.1 million for the same period of fiscal 2025, and grew 9% sequentially, compared to $52.6 million for the first quarter of fiscal 2026. Shipped products to approximately 2,583 customers in the second quarter of fiscal 2026, versus approximately 2,431 in the same period of fiscal 2025. •Physically shipped approximately 300,000 genes in the second quarter of fiscal 2026, compared with approximately 227,000 in the same period of fiscal 2025. For the full fiscal year 2026, Twist expects: Total revenue in the range of $442 million to $447 million, growth of 17% to 19%, compared to prior guidance of $435 to $440 million. •Gross margin to be above 52% for fiscal 2026 For the third quarter, Twist expects: •Total revenue of approximately $114 million to $115 million, growth of approximately 19% year over year at the midpoint. As previously discussed, we expect NGS to be the driver of sequential growth in H2 and return to 20% growth by 4Q. For the fourth quarter, Twist expects: •To achieve adjusted EBITDA breakeven for the fourth quarter of fiscal 2026 Shares -2.4% PM. More on Twist Bioscience Twist Bioscience Corporation (TWST) Presents at Barclays 28th Annual Global Healthcare Conference Transcript Twist Bioscience Corporation (TWST) Shareholder/Analyst Call Transcript Twist Bioscience Corporation (TWST) Shareholder/Analyst Call - Slideshow Twist Bioscience Q2 2026 Earnings Preview Twist Bioscience falls after over $2M insider sale
DKosig Deutsche Bank lifted its rating on Packaging Corporation of America ( PKG ) to Buy from Neutral on its view that a positive inflection point creates an attractive opportunity for investors. Analyst Hillary Cacanando said the firm believes Packaging Corporation of America ( PKG ) is at a positive inflection point based on its per-day shipment growth that has significantly outpaced the broade...
DKosig Deutsche Bank lifted its rating on Packaging Corporation of America ( PKG ) to Buy from Neutral on its view that a positive inflection point creates an attractive opportunity for investors. Analyst Hillary Cacanando said the firm believes Packaging Corporation of America ( PKG ) is at a positive inflection point based on its per-day shipment growth that has significantly outpaced the broader market. "The combination of accelerating demand, exceptional operational prowess, and a successful integration of the Greif acquisition presents an attractive investment opportunity, in our view," updated Cacanando. The integration of the recently purchased Greif containerboard assets was noted to be exceeding initial expectations. Cacanando and her team believe the progress provides a clear line of sight to achieving the $60M synergy target. A potential industry-wide increase in containerboard prices is also seen as providing PKG a lift. Deutsche Bank assigned a price target of $256 to Packaging Corporation of America ( PKG ). More on Packaging Corp Packaging Corporation of America (PKG) Q1 2026 Earnings Call Transcript Packaging Corporation of America: Valuation Remains Full Despite A Solid Q1 Packaging Corporation of America (PKG) Presents at Bank of America 2026 Global Agriculture and Materials Conference - Slideshow PCA expects $2.33 in Q2 2026 EPS excluding special items as price benefits build into Q3 Packaging Corp of America tops profit estimates as box demand improves
A Hong Kong government-backed artificial intelligence lab is preparing to launch a new model built on DeepSeek that can run entirely on Chinese-made chips. The Hong Kong Generative AI Research and Development Centre (HKGAI) plans to unveil its HKGAI-V3 model in the first half of this year as it looks to export its “sovereign AI” capabilities to overseas markets. The system was based on DeepSeek V4...
A Hong Kong government-backed artificial intelligence lab is preparing to launch a new model built on DeepSeek that can run entirely on Chinese-made chips. The Hong Kong Generative AI Research and Development Centre (HKGAI) plans to unveil its HKGAI-V3 model in the first half of this year as it looks to export its “sovereign AI” capabilities to overseas markets. The system was based on DeepSeek V4 architecture with “full-parameter fine tuning for localisation”, and had been optimised to operate...
SPRINGDALE, Ark., May 04, 2026 (GLOBE NEWSWIRE) -- Tyson Foods, Inc. (NYSE: TSN) today announced its second quarter 2026 financial results through an earnings release available on the company’s Investor Relations website at https://ir.tyson.com . Management will host a conference call and webcast beginning at 9:00 a.m. Eastern Time (8:00 a.m. Central Time). The earnings release will be furnished w...
SPRINGDALE, Ark., May 04, 2026 (GLOBE NEWSWIRE) -- Tyson Foods, Inc. (NYSE: TSN) today announced its second quarter 2026 financial results through an earnings release available on the company’s Investor Relations website at https://ir.tyson.com . Management will host a conference call and webcast beginning at 9:00 a.m. Eastern Time (8:00 a.m. Central Time). The earnings release will be furnished with the Securities and Exchange Commission (SEC) on a Form 8-K.